Real-time enrollment status for this estrogen receptor-positive breast carcinoma clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 2:20 AM UTC
| NCT Number | NCT06450873 |
| Recruiting Status | Recruiting |
| Condition | Estrogen Receptor-Positive Breast Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | March 31, 2026 (Mar 31, 2026) |
As of July 21, 2026: Clinical trial NCT06450873 is currently recruiting participants. This phase2 study for estrogen receptor-positive breast carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06450873 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06450873 was last updated Mar 31, 2026 (March 31, 2026). HelloStudys verifies this status automatically.